Sanara MedTech Net Profit Margin 2014-2025 | SMTI
Sanara MedTech net profit margin from 2014 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Sanara MedTech Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $0.09B | $-0.01B | -14.29% |
| 2024-12-31 | $0.09B | $-0.01B | -12.64% |
| 2024-09-30 | $0.08B | $-0.01B | -11.39% |
| 2024-06-30 | $0.07B | $-0.01B | -9.59% |
| 2024-03-31 | $0.07B | $-0.01B | -7.25% |
| 2023-12-31 | $0.07B | $0.00B | -6.06% |
| 2023-09-30 | $0.06B | $-0.01B | -12.70% |
| 2023-06-30 | $0.06B | $-0.01B | -13.33% |
| 2023-03-31 | $0.05B | $-0.01B | -9.26% |
| 2022-12-31 | $0.05B | $-0.01B | -15.22% |
| 2022-09-30 | $0.04B | $-0.01B | -18.42% |
| 2022-06-30 | $0.03B | $-0.01B | -25.81% |
| 2022-03-31 | $0.03B | $-0.01B | -37.04% |
| 2021-12-31 | $0.02B | $-0.01B | -33.33% |
| 2021-09-30 | $0.02B | $0.00B | -18.18% |
| 2021-06-30 | $0.02B | $0.00B | -15.00% |
| 2021-03-31 | $0.02B | $0.00B | -17.65% |
| 2020-12-31 | $0.02B | $0.00B | -25.00% |
| 2020-09-30 | $0.01B | $-0.01B | -35.71% |
| 2020-06-30 | $0.01B | $-0.01B | -38.46% |
| 2020-03-31 | $0.01B | $0.00B | -30.77% |
| 2019-12-31 | $0.01B | $0.00B | -18.18% |
| 2019-09-30 | $0.01B | $0.00B | -10.00% |
| 2019-06-30 | $0.01B | 0 | 0.00% |
| 2019-03-31 | $0.01B | 0 | 0.00% |
| 2018-12-31 | $0.01B | 0 | 0.00% |
| 2018-09-30 | $0.01B | 0 | 0.00% |
| 2018-06-30 | $0.01B | 0 | 0.00% |
| 2018-03-31 | $0.01B | 0 | 0.00% |
| 2017-12-31 | $0.01B | 0 | 0.00% |
| 2017-03-31 | $0.00B | $0.00B | -33.33% |
| 2016-06-30 | $0.00B | $0.00B | -33.33% |
| 2016-03-31 | $0.00B | $0.00B | -33.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.258B | $0.087B |
| Wound Management Technologies Inc. develops and markets wound care products. It develops, markets and distributes biotechnology products to physicians, hospitals and clinics. The Company markets collagen-based products for the treatment of pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns and superficial wounds. It sells and distributes CellerateRX(R) Surgical Activated Collagen(R) Adjuvant as well as HemaQuell(R) Resorbable Bone Hemostat. Wound Management Technologies Inc. is based in Fort Worth, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.407B | 27.95 |
| Boston Scientific (BSX) | United States | $155.727B | 38.99 |
| Stryker (SYK) | United States | $146.049B | 30.54 |
| EssilorLuxottica (ESLOY) | France | $127.608B | 0.00 |
| Medtronic (MDT) | Ireland | $106.425B | 15.09 |
| Haleon (HLN) | United Kingdom | $51.105B | 29.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.009B | 0.00 |
| ResMed (RMD) | United States | $35.893B | 26.96 |
| GE HealthCare Technologies (GEHC) | United States | $32.299B | 15.34 |
| Agilent Technologies (A) | United States | $31.909B | 20.73 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Insulet (PODD) | United States | $22.874B | 89.79 |
| Koninklijke Philips (PHG) | Netherlands | $21.656B | 15.57 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.236B | 11.71 |
| Baxter (BAX) | United States | $15.652B | 11.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.683B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.175B | 21.49 |
| Lantheus Holdings (LNTH) | United States | $5.228B | 13.19 |
| Prestige Consumer Healthcare (PBH) | United States | $4.233B | 18.91 |
| Perrigo (PRGO) | Ireland | $3.680B | 9.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.319B | 24.48 |
| Haemonetics (HAE) | United States | $3.253B | 14.82 |
| Envista Holdings (NVST) | United States | $3.097B | 25.73 |
| GN Store Nord (GNNDY) | Denmark | $2.224B | 18.42 |
| QuidelOrtho (QDEL) | United States | $2.074B | 14.27 |
| LeMaitre Vascular (LMAT) | United States | $1.857B | 41.51 |
| AtriCure (ATRC) | United States | $1.711B | 0.00 |
| Acuren (TIC) | United States | $1.276B | 0.00 |
| Neogen (NEOG) | United States | $1.272B | 16.28 |
| AdaptHealth (AHCO) | United States | $1.212B | 12.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.156B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.109B | 24.95 |
| BioLife Solutions (BLFS) | United States | $1.039B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.990B | 12.65 |
| InMode (INMD) | Israel | $0.927B | 9.34 |
| CeriBell (CBLL) | United States | $0.608B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.573B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Owens & Minor (OMI) | United States | $0.510B | 4.23 |
| Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.428B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.62 |
| Aurora Cannabis (ACB) | Canada | $0.298B | 53.00 |
| Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.263B | 22.17 |
| ZimVie (ZIMV) | United States | $0.255B | 11.57 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.243B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.229B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.224B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Quanterix (QTRX) | United States | $0.202B | 0.00 |
| Brainsway (BWAY) | Israel | $0.193B | 51.00 |
| Biote (BTMD) | United States | $0.189B | 5.32 |
| TriSalus Life Sciences (TLSI) | United States | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Omeros (OMER) | United States | $0.181B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.57 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 0.00 |
| Jin Medical (ZJYL) | China | $0.118B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Agape ATP (ATPC) | $0.087B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.029B | 38.86 |
| Safety Shot (SHOT) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |